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Abstract
Epigenetic gene regulation is a dynamic process orchestrated by chromatin-modifying enzymes. 
Many of these master regulators exert their function through covalent modification of DNA and 
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histone proteins. Aberrant epigenetic processes have been implicated in the pathophysiology of 
multiple human diseases. Small-molecule inhibitors have been essential to advancing our 
understanding of the underlying molecular mechanisms of epigenetic processes. However, the 
resolution offered by small molecules is often insufficient to manipulate epigenetic processes with 
high spatio-temporal control. Here, we present a novel and generalizable approach, referred to as 
‘Chemo-Optical Modulation of Epigenetically-regulated Transcription’ (COMET), enabling high-
resolution, optical control of epigenetic mechanisms based on photochromic inhibitors of human 
histone deacetylases using visible light. COMET probes may translate into novel therapeutic 
strategies for diseases where conditional and selective epigenome modulation is required.
Introduction
Epigenetic mechanisms are critical to the dynamic regulation of activity-dependent gene 
expression and play key roles in many physiological processes including cell proliferation, 
neuroplasticity, and regulation of the circadian clock 1–3. At the biochemical level, these 
mechanisms involve the interplay of histone-modifying complexes, which alter the N-
terminal tails of histone proteins through post-translational modifications, ATP-dependent 
nucleosome remodeling complexes, and DNA methylation4.
The utilization of small-molecule probes as tools to interrogate the biology of epigenetic 
gene regulation has tremendously increased our knowledge and provided detailed insights 
into mechanisms essential to the dynamic regulation of the human genome 5. Small 
molecules provide an orthogonal and complementary approach to genetic methods 6,7. 
However, the precision offered by small molecules is generally confined by pharmacokinetic 
principles and is often insufficient when high spatio-temporal resolution is required.
Over the last decade, extensive efforts have been dedicated to develop technologies that 
enable the use of light to modulate biological functions. Light is a reagent that can be 
applied and controlled with unparalleled precision both temporally and spatially. 
Optogenetic methods, which have revolutionized neuroscience, are based on transgenic 
neurons with photo-responsive ion channels that allow for real-time manipulation of 
individual neurons ex vivo and in live animals 8. More recently, the development of 
genetically encoded light-inducible transcriptional effectors has enabled targeted gene 
activation 9.
Similarly, small molecules with unique chemical motifs, which can be switched reversibly 
between two distinct geometries upon exposure to light of a specific wavelength, have 
attracted attention in protein engineering and small-molecule probe design 10,11. This 
methodology holds tremendous potential for improving our ability to precisely control key 
biological systems that can overcome many of the limitations of currently available 
pharmacological inhibitors, without the need for genetically engineered cell lines or 
organisms as required by optogenetic approaches 12. However, to date, successful 
implementations have been limited to applications that are characterized by threshold-
triggered responses, such as the inhibition of ion channels 13,14, while efficient inhibition of 
enzyme functions with high spatio-temporal control has not been accomplished.
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Here, we report the development of a novel concept, referred to as Chemo-Optical 
Modulation of Epigenetically-regulated Transcription (COMET), which combines fast-
relaxing photochromic ligands and small-molecule inhibitors with long target-residence time 
to enable the development of tool compounds that allow for high spatio-temporal control of 
the epigenome. Based on this strategy, we have designed class and isoform-selective 
inhibitors of human histone deacetylases (HDACs). We demonstrated that the COMET 
probes exhibit up to three orders of magnitude increased potency when exposed to blue light 
and allow for optically controlled HDAC-dependent modulation of gene expression in living 
human cells.
Results
Conceptual Approach
The limited success in developing light-controlled enzyme modulators is in part inherent to 
the molecular properties of currently employed photoswitches. Generally, a photochromic 
ligand can adopt two distinct geometries, which represent the thermodynamic ground state 
and a metastable higher-energy state 10. With azobenzenes, the most widely used 
photochromic ligand for biological studies to date, the respective states correspond to the 
trans and cis isomers (Fig. 1a). Trans/cis isomerization can be induced with ultraviolet (UV)/
visible (Vis) light, and the ratio of both isomers obtained after irradiation under equilibrium 
conditions inversely correlates to the absorbance coefficient at the wavelength used for 
isomerization. In virtually all reported examples, both isomers have absorbance overlap at 
any given wavelength, and the ratio of the respective absorption coefficients is generally less 
than 10. Therefore, light-induced isomerization can never be quantitative in terms of 
complete transformation as it does not allow for >10:1 enrichment, and consequently light-
induced “deactivation” will generally retain >5 % of the active isomer 15. While this can be 
sufficient for modulating a threshold-based biological function, such as an ion channel 
opening, it is generally not suitable to study differential enzymatic activity in a cellular 
context (Fig. 1b). In contrast, thermal relaxation from the metastable state (cis) to the 
thermodynamic ground state (trans) is quantitative. However, the rate constants depend 
highly on the electronic nature of the substituents, and half-lives can vary from 
microseconds to weeks15.
Most efforts using azobenzenes in biological settings have focused on compounds with 
medium to long thermal relaxation half-lives (minutes to weeks), while compounds with 
short and very short (sub-milliseconds to seconds) thermal relaxation half-lives are generally 
considered less attractive 10,11,15. The rationale is based on the notion that maintaining a 
significant population of the cis isomer of a photoswitchable compound is required for 
sustained inhibition of the target. Compounds with fast thermal relaxation would 
consequently require very high light intensity and continuous exposure, which in turn could 
result in thermal stress or damage to the biological specimen. We hypothesized that this 
concern, while valid for target-inhibitor pairs that follow the standard Michaelis-Menten 
model with fast equilibrium kinetics, would not apply for small-molecule ligands with long 
target-residence times 16. Conversely, the seemingly unattractive feature of rapid thermal 
relaxation would become an advantage when applied to probes with long residence times. 
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That is, provided that the metastable isomer corresponds to the active isomer, such ligands 
should be stabilized and remain engaged with the target following light exposure, thus 
eliminating the requirement for constant exposure 17,18. Unbound ligands will rapidly revert 
to the ground state in the absence of light, which would allow for precise confinement of 
small molecule activity. Here, we demonstrated that this can indeed be the case using 
azobenzene-based photochromic compounds designed to target HDAC family members that 
enable optical control of epigenetic mechanisms for the first time without the need for 
genetically engineered responsive cells.
Inhibitor design
Thermally fast relaxing azobenzenes commonly feature an electron-donating substituent on 
one benzene ring and an electron-withdrawing substituent on the other. These “push-pull” 
azobenzenes strongly absorb light in the visible electromagnetic spectrum, which allows for 
photoisomerization using well-tolerated blue light, rather than less biocompatible UV light. 
Furthermore, changes of overall electronic properties as result of cis isomerization are more 
pronounced compared to azobenzenes with symmetric substitution patterns. We have 
exploited this feature in our design of photochromic HDAC inhibitors that are formal 
hybrids of para-methyl red (DABCYL), which is commonly used as a biocompatible 
fluorescence quencher, and an ortho-amino anilide (OAA) HDAC inhibitor such as CI-994 
(Tacedinaline), Merck Compound-60 (C60) (Fig. 1c) and MS-275 (Entinostat) 19. OAA and 
the corresponding hydroxyl analogs are characterized by long target-residence time and 
show remarkable preference for inhibiting the deacetylase activity of class I HDACs1-3 over 
the other eight zinc-dependent HDAC isoforms 20,21. OAA (or hydroxyl analogs) chelate the 
catalytic zinc in the active site of HDAC enzymes 19. The zinc binding affinity of the OAA 
is sensitive to electronic effects, and electron rich substituents are generally not well 
tolerated 22. Following this design strategy, we synthesized BG14 (1), BG47 (2), and BG48 
(3) as prototype COMET HDAC inhibitors, and BG12 (4) as control compound that lacks 
the dimethylamino substituent (Fig. 1c, d). BG47 and BG48 feature a 4-(2′-thienyl)-
substituted benzamide analogous to C60, which was predicted to provide selectivity for 
HDAC1/2 over HDAC3 19.
Based on the published crystal structures of HDAC2 with benzamide inhibitors (3MAX and 
4LY1) 19,23 suggesting that the 4-dimethylamino phenyl moiety of these prototypical 
COMET HDAC inhibitors would be solvent exposed, as well as the published structure-
activity-relationship of OAA series, we considered that the steric change as result of trans-
to-cis isomerization would not significantly alter the affinity for the targeted HDAC 
isoforms. As an alternative, we hypothesized that disruption of the electron-donating effect 
of the DABCYL moiety as a result of the trans-to-cis isomerization would significantly 
change the overall electronic properties of the HDAC-targeting anilide and as a consequence 
increase the zinc-chelating ability of the cis isomers. To test this hypothesis, we performed 
density functional theory (DFT) calculations (Gaussian 09) using B3LYP with the 
6-31+G(d) basis set to compute the electrostatic potential of the prototypic inhibitor BG14 in 
the trans and cis geometries in comparison to the reference inhibitor CI-994. As shown in 
Figure 1e, the electronic potentials of the benzamide carbonyl-oxygen and the aniline-
nitrogen, which together chelate the active site zinc in the ligand-HDAC complex 19,23, were 
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less negatively charged and more similar to CI-994 in the cis isomer than the 
thermodynamically favored stable trans isomer. These computational data supported the 
hypothesis that optical modulation of the electronic properties of zinc-chelating HDAC 
inhibitors provides a novel means to control HDAC activity using COMET probes.
Inhibitor characterization and biochemical profiling
Physical characterization of the prototype COMET HDAC inhibitors in PBS confirmed that 
all compounds strongly absorb light in the blue spectrum with maximum absorbance around 
470 nm (Supplementary Results, Supplementary Fig. 1), which renders them suitable for 
biological exploration.
Thermal relaxation half-lives of push-pull azobenzene analogs similar to the presented 
compounds in aqueous solution at physiological pH have, to the best of our knowledge, not 
been reported. Previous approaches to study fast cis-to-trans isomerization are based on laser 
flash photolysis to measure the transient absorbance change following excitation with a short 
laser pulse24. Such experimental setups offer picosecond resolution; however, they are 
expensive and not commonly accessible. As an alternative, to measure relaxation kinetics 
with microsecond resolution, we designed a readily adaptable instrumentation setup 
(Supplementary Fig. 2 and Supplementary Fig. 3). Using this approach, we determined the 
thermal relaxation half-lives of HDAC ligands to range from 55–60 μs, relative to 47 μs for 
DABCYL, which is approximately 120× faster than previous measurements for DABCYL in 
chloroform (Fig. 2a) 17. The estimated distance of diffusion of small molecules (diffusion 
coefficient D = 10−6–10−7cm2/s) at 10×T1/2 (500 μs) in water is 0.1–0.3 μm, and is therefore 
expected to limit diffusion of “activated” inhibitors well within subcellular dimensions.
To allow for high-throughput profiling of biochemical and cellular activity with COMET, we 
designed and optimized microprocessor-controlled (using the open-source Arduino 
platform) 12×8 light-emitting diode (LED)-arrays that are compatible with 96-well 
microtiter plates and may be used in standard tissue culture incubators due to their self-
contained nature and small footprint (Fig. 2b, Supplementary Fig. 4, Supplementary Fig. 5, 
Supplementary Video 1).
Using an LED array equipped with blue (470 nm) LEDs, which we identified to be best 
suited for the tested compounds (Supplementary Fig. 6), we were able to accurately profile 
the light-dependent HDAC inhibitory activity of the COMET probes using a biochemical 
assay measuring the deacetylation of a synthetic acetyl-lysine tripeptide substrate based on 
histone H4 Lysine 12 (Fig. 2c–f) 20. Following exposure to blue light (470 nm), but not in 
the absence of light, BG14, BG47 and BG48 strongly inhibited the enzymatic activity of 
HDAC1 (Fig. 2d) and HDAC2 (Fig. 2e) in dose-dependent fashion while no differential 
activity upon light exposure was observed for the reference HDAC inhibitors CI-994 and 
MS-275, respectively 20. As expected, profiling of the COMET probe set against HDAC3 
(Fig. 2f) revealed that only BG14 potently inhibited enzymatic activity in a light-dependent 
fashion, while BG47 and BG48 did not inhibit HDAC3 in either the presence or absence of 
light, which also indicated that the inhibitory activity was not the result of non-specific 
inhibition. Furthermore, as shown for BG14 and HDAC3, the inhibitory activity was 
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dependent on light intensity (Fig. 2c), demonstrating that the degree of target inhibition can 
be optically controlled.
In addition, BG12, a close analogue of BG14 that does not feature the dimethylamino 
substituent, which we deemed to be responsible for the low affinity of the COMET probes in 
trans-geometry because of its electron-donating effect, potently inhibited both HDAC 
isoforms in trans-geometry and did not exhibit differential potency upon photoisomerization 
(Supplementary Fig. 7). These results supported our hypothesis that electronic, rather than 
steric effects, are the major drivers for the differential activity of the COMET probes upon 
light activation. Consistent with our mechanistic predictions, the COMET probes exhibited 
long target residence times, which is characteristic for benzamide-based HDAC inhibitors. 
As illustrated in Figure 2 g–i, the enzymatic activity recovered in a time-dependent fashion 
following light exposure. Specifically, HDAC1, which we found to be most stable under 
longer biochemical assay condition, was incubated with varying concentrations of BG47 or 
BG48 and exposed for 1 h to 470 nm light of constant intensity (470 nm, 17 mW/cm2) 
followed by a variable period without light. In the absence of light, unbound COMET probes 
were inactive, and enzyme-bound inhibitors dissociated at a rate governed by koff and 
thereby liberated catalytically active HDAC. Because unbound COMET probes quickly 
relaxed to the inactive trans-isomer, dissociation was essentially irreversible.
Inhibitor In Vitro Profiling
Following the biochemical characterization of the COMET probes, we profiled BG14, 
BG47, and BG48 in cellular assays using acetylation of histone H3 Lysine 9 (H3K9ac) as a 
pharmacodynamic marker for HDAC inhibition. As shown in Figure 3, treatment of MCF-7 
cells (a human breast cancer cell line) with BG14 in the presence of light for 16 hours 
strongly induced acetylation of H3K9 relative to the vehicle control comparable to CI-994 
treatment in an immunofluorescence assay (Fig. 3 a, b). H3K9 acetylation levels directly 
correlated with total light exposure (Fig. 3 c–e, Supplementary Fig. 8) as quantified by 
western blot analysis. Independently of the assay method, we did not observe significant 
increase in histone acetylation in the absence of light. As expected, BG14, which also 
inhibited HDAC3, induced the strongest increase of H3K9ac (Fig. 3c) compared to the 
HDAC1/2-selective inhibitors BG47 (Fig. 3d) and BG48 (Fig. 3e). These results with 
COMET probes demonstrated, for the first time, light-dependent control of the human 
epigenome.
Next, we investigated the time dependence and persistence of HDAC inhibition following 
light exposure and measured H3K9ac, which is a highly dynamic histone modification, 25 
after varying periods of light exposure and dark recovery. As shown in Figure 3f (see 
Supplementary Fig. 9 for detailed analysis), H3K9ac levels increased with prolonged 
exposure to 470 nm light and plateaued around 4–8 h at an intensity level that is comparable 
to the effect observed with CI-994. Importantly, H3K9 acetylation levels were persistent for 
over 8 h without light exposure, consistent with prolonged inhibition of HDAC activity as a 
consequence of the long residence time of our inhibitors. These results were in good 
agreement with the biochemical profiling data demonstrating optical control of HDAC 
inhibition.
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To demonstrate spatial control within a cell population, we exposed MCF-7 cells grown in a 
1-well chamber slide in the presence of BG14. Using our 96-well LED array, we exposed 
one side to blue light from a single LED for 6 h followed by 10 h in the dark and quantified 
histone H3K9ac by immunofluorescence staining. As shown in Figure 4a, significant 
increase of H3K9 acetylation was limited to the light exposed areas within the same 
chamber.
To further explore the degree of spatial control that is achievable with our current LED 
matrix, we repeated the experiment in 96-well plates—a format that will enable high-
throughput discovery and facilitate exploration of the biological effects of COMET probes 
under a range of experimental conditions. Light exposure was restricted to one-half of each 
well that was covered on the bottom with black tape, and MCF-7 cells were treated as 
described above. As shown in Figure 4b, neither DMSO nor CI-994 treated wells showed 
differential histone H3K9ac in light-exposed and non-exposed areas. In contrast, BG14 
strongly induced histone H3K9ac in the light-exposed portion of the well to levels 
comparable to CI-994. Only a slight increase of histone H3K9ac was detectable in the 
covered portion of the well (Fig. 4c), which we speculated was not caused by diffusion of 
cis-BG14, which would have resulted in an activity gradient, but by partial internal light 
reflection and light scattering on the air/liquid and liquid/plastic interface that can be 
overcome in the future by improved optical delivery methods. Nonetheless, our results 
demonstrated that the HDAC inhibitory activity of BG14 can at least be confined within < 1 
mm.
Having demonstrated light-dependent control of the acetylation state of the epigenome using 
COMET probes, we next sought to determine the biological consequence of HDAC 
inhibition at the level of the transcriptome in comparison to conventional light-independent 
HDAC inhibitors. To gain quantitative insights into the specific genes regulated by the 
COMET probes under a wide range of experimental conditions, including variation of 
compound dose, treatment time, and light exposure, we performed high-throughput gene 
expression profiling using the L1000 method from Genometry (Genometry, Inc.). The 
L1000 assay is a novel, high-throughput, multiplexed mRNA expression profiling technique 
developed as part of the NIH Common Fund supported LINCS project. It is based on the 
direct measurement of a reduced representation of the transcriptome (978 ‘landmark’ 
transcripts) and inference of the portion of the transcriptome not explicitly measured using 
an algorithm trained on tens of thousands of historical microarray-derived gene expression 
profiles. Eighty invariant transcripts are also explicitly measured to enable scaling and 
normalization. Specifically, we treated human MCF-7 cells and measured transcriptional 
changes as a function of compound concentration, light exposure, and treatment duration 
relative to the reference HDAC inhibitor CI-994. Light treatment alone or treatment with 
COMET probes in the absence of light had little to no effect on gene expression, while 
numerous light-dose and compound-concentration dependent transcriptional changes were 
observed in the presence of light. As expected for HDAC inhibition and consistent with 
previous reports, BG14 induced both up- and down-regulation of specific transcripts as 
illustrated by the examples of the directly measured landmark genes PAK1 and CDK2 (Fig. 
5a, b).
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To obtain a more comprehensive assessment of the light-dependent activity of BG14, we 
performed a global gene expression analysis (using directly measured and inferred genes) 
and ranked the top 100 up- and down-regulated genes, respectively (Fig. 5c, Supplementary 
Fig. 10). The relative expression changes directly correlated with average light exposure and 
inhibitor concentration. Importantly, light or inhibitor treatment alone did not induce 
meaningful changes in the respective transcript levels for the majority of transcripts. Use of 
Gene Set Enrichment Analysis (GSEA) 26 to compare the expression patterns of BG14 with 
CI-994 demonstrated a high correlation between the respective expression profiles under 
light treatment conditions, establishing strong support for similar biological activity (Fig. 5d, 
Supplementary Fig. 11).
Interestingly, albeit fewer genes, a more significant correlation was observed between 
COMET HDAC inhibitors and reference HDAC inhibitors in the absence of light. Given the 
low HDAC inhibitory activity of BG14 and the absence of measurable induction of histone 
acetylation under these conditions in the biochemical assays described above, these results 
suggested that the observed transcriptional changes may be caused by off-target (i.e. non 
HDAC related) effects that are common to BG14 and CI-994, which share high chemical 
similarity. To explicitly differentiate off- and on-target effects of BG14, we analyzed the 
L1000 gene expression profiles for light-induced, dose-dependent changes. Following a 16 h 
treatment with and without light, BG14 significantly (normalized expression score > 1.5) 
changed the expression of 234 and 69 landmark genes, respectively (Fig. 5e, Supplementary 
Fig. 12, Supplementary Data Set 1). Of the 69 genes that were differentially expressed by 
BG14 treatment alone (without light), 22 genes (“off-target genes”) were not further 
modulated in the presence of light, while 47 genes (“mixed on-target”) showed significant 
additional expression changes in the presence of light. Strikingly, the two sets showed 100% 
and 83% overlap with the CI-994 signatures. Notably, 187 (“on-target”) of 234 genes (80%) 
were only differentially expressed following BG14 exposure in the presence of light, and 
120 (65%) of these on-target genes (“Core Gene Set”) overlapped with the 432 CI-994 
responsive genes. A network analysis of the 120 Core Gene Set identified pathways 
associated with cell cycle regulation and mitochondrial function (Supplementary Fig. 13a), 
consistent with the well-established biological consequence of HDAC inhibition 27,28. 
Furthermore, the genes in the cell cycle-related networks comprised a large proportion of the 
top 25 down-regulated genes within the Core Gene Set (Supplementary Fig. 13b). Similar 
results were obtained for the analysis of all BG14 on-target genes. In contrast, the network 
analysis of off-target genes did not identify any specific biological pathways with any 
statistical significance (FDR < 0.05). Additionally, we identified 343 responsive genes for 
the HDAC 1/2 inhibitor C60, of which 59% overlapped with CI-994. Comparably, 53% of 
BG14 on-target and 73% off-target genes corresponded to the C60 gene signature, further 
strengthening the observed HDAC inhibitory function of our COMET probe.
Discussion
The ability to modulate the function of chromatin-modifying enzymes with high spatio-
temporal control in cells and tissues will be critical to enable a deeper understanding of the 
molecular basis and physiological consequences of epigenetic gene regulation. In the studies 
presented here, we have established COMET as a novel approach to modulate the activity of 
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specific HDAC isoforms using small molecules with high precision, and have demonstrated 
that this inhibition of HDACs can be correlated to changes in gene expression, providing a 
novel means to control the transcriptome without the need to generate genetically-
engineered cell lines or transgenic organisms. Given the optical and pharmacological 
properties of the COMET probes, our data suggest that these tools will enable inhibition of 
HDAC function with subcellular resolution in living cells and potentially whole organisms, 
with previously unmatched precision. Future applications in vivo of COMET HDAC probes 
may yield novel insight into complex biological processes where the afforded spatio-
temporal control will be invaluable, such as memory formation 1, as well as novel 
therapeutic strategies for disorders with epigenetic dysregulation, including 
neurodegeneration 29,30, stress responses 31,32, and oncogenesis 33. Of particular interest in 
this context is to selectively target defined regions of tissues, for example to establish a dose-
response study within the same tumor sample or regions of a tissue in the nervous system 
that are known to exhibit different effects on a neurocircuit, in order to better understand the 
spatial-temporal regulation of biological function.
Polypharmacology of small molecules is well recognized, and specific or non-specific 
binding to secondary targets can contribute to the global biological response 34. Off-target 
effects mediated by unknown or unintended targets can complicate the use of 
pharmacological probes to dissect protein function. Commonly used “best practices” most 
often rely on comparative analysis of active versus inactive molecules differing in structural 
elements. Since structurally distinct molecules can exhibit significantly altered 
physicochemical and other properties (e.g. cell permeability, metabolism, stability), such 
differences may confound the interpretation of the resulting biological effects. Alternatively, 
as we demonstrated here with COMET HDAC inhibitors, exploiting the photochromic 
properties of molecules offers the compelling advantage of allowing comparison of the same 
molecular entity in inactive versus active states. In particular for photochromic ligands with 
fast thermal relaxation kinetics, the fraction of free ligand in the thermodynamically 
unfavored state will be very small and only exist during periods of light exposure. In 
addition, off-target interactions caused by such photochromic ligands that are specific to the 
thermodynamically unfavored state are expected to be transient except for off-target 
interactions that are also characterized by very slow dissociation kinetics. However, 
differential membrane diffusion kinetics altering cell permeability may be observed as a 
consequence of the distinct molecular geometries and consequently alter the kinetics of 
cellular uptake kinetics. This concern will especially apply for measurements performed 
within minutes of ligand addition in a pre-equilibrium state and should be characterized by 
the absence of off-target effects in the non-light control.
Having developed a readily accessible and extensible platform for optoepigenetic profiling 
using LED arrays, we expect that this approach will furthermore be compatible with 
instrumentation setups that are commonly already used for optogenetic studies and will thus 
be readily implemented. We note that while the very long target residence time can represent 
an advantage for applications that require prolonged target inhibition, it will nonetheless be 
desirable in the future to develop analogs with shorter residence time for experimental 
designs that require tight temporal control over target-ligand dissociation. Here our Arduino-
based, microprocessor-controlled LED-array platform will greatly improve the throughput of 
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discovering novel photochromic probes and optimizing their use in biological systems. Thus, 
upon the identification of ligands with optimized residence times for other targets, as well as 
the future development of photochromic scaffolds specifically tuned for in vivo use, a novel 
optically-based pharmacology for biological investigation and therapeutic applications can 
be envisioned.
Online Methods
Measurement of cis-to-trans Relaxation
The lifetime of the active molecule was measured by recording the time evolution of the 
optical absorbance of the solution. Conventional instruments are poorly suited for making 
this measurement because the change happens relatively quickly (on the order of 100 μs) and 
the percentage change in absorbance is small. We developed our instrumentation setup 
specifically to measure the rate at which the absorbance returns to its resting rate following 
photo activation.
Optical Excitation System—A single 405 nm laser diode (US Lasers D405-120) was 
used both to activate the sample and to probe the optical density. During activation, 8 V was 
applied across the laser diode for 100 μs with 10 μs rise and fall times by an arbitrary 
waveform generator (Tektronix AFG3252). The activation pulse was repeated at a frequency 
of 1 kHz. Between activation pulses, 3.6 V was applied across the laser diode to produce a 
beam for probing the optical density of the sample. The laser power was measured 
independently in activation and probing mode by alternating between the mode of the 
interest and turning the laser completely off. The average power was then measured using a 
laser power meter (Edmund Optics Lasercheck). The transient power during each mode was 
then calculated as 13.8 mW during activation and 17.4 μW during probing by virtue of the 
known duty cycle.
Optical Measurement System—The optical signal was converted to charge using an 
avalanche photodiode (Hamamatsu Si APD S2382) operating well below its avalanche 
threshold to achieve high linearity and high speed. The cathode was biased at 30V from a 
bench top power supply (Keithley 2402 Sourcemeter). The anode was connected to a 
transimpedance amplifier built out of an operational amplifier (Analog Devices AD8532) 
with resistive feedback as shown in Supplementary Fig. 2. This operational amplifier was 
chosen primarily based on its low input bias current of 5pA along with sufficient speed (3 
MHz bandwidth) and rail-to-rail operation. A 500kΩ resistor was used to convert the current 
from the photodiode to a voltage at 0.5V per μA.
The output signal from the transimpedance amplifier contained an offset of approximately 4 
Volts. This offset was reduced in order to digitize the signal at the maximum gain on the 
oscilloscope, and a second operational amplifier was used to adjust this offset. The same 
type of operational amplifier was used in the second stage, here configured as an inverting 
stage. A potentiometer was used to control the constant voltage that was subtracted from the 
output of the first stage (V1). In order to accurately place the final output (V2) around earth 
ground, the circuit used a negative supply at −0.8 V.
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The output of the measurement circuit was digitized using a 1GHz real time oscilloscope 
(Tektronix MSO 4104). The channel was configured for 1MΩ input with a 200μs time base 
and a 20mV vertical scale. Averaging was performed on the oscilloscope over 128 traces. 
The data was then transferred from the oscilloscope over a universal serial bus (USB) 
connection to a computer running Matlab (Mathworks). Ten such traces were then acquired 
and averaged. An illustration of the entire measurement system is depicted in Supplementary 
Fig. 3.
Optical Measurement Procedure—Stock solutions (0.5 mM) of test compounds were 
prepared in dimethylformamide (DMF) (Fisher) and diluted 100:1 in phosphate buffered 
saline (PBS) (Fisher). 100 μL of the solution was then transferred into a semi-micro 10 mm 
cuvette (Fisher 14-955-127). A blank cuvette was prepared with 100 μL of PBS.
For each sample, ten measurements were made of the blank as well as the sample itself. The 
light absorbed by the sample was calculated by taking the difference between the data 
measured for the blank and the data measured for the sample. The difference signals for all 
ten runs were then averaged together. The averaged signal was filtered through a 100 kHz 
lowpass filter (5-tap infinite-impulse response Butterworth) to remove high frequency noise. 
A least-squared fit modeling a one-phase decay (Graphpad Prism) was used to determine the 
relaxation half-lives. Values are reported as 95% Confidence Intervals.
Microplate-compatible 8x12 LED Array
To allow for high-throughput profiling, we have developed microprocessor controlled 12 x 8 
LED arrays that match the standardized 96-well microplate layout (figure 4). The 
experimental setups were assembled from four modular units (PCB board with LEDs, 
microplate stage, microcontroller, power source) (Supplementary Fig. 4 and Supplementary 
Fig. 5).
PCB board with LEDs—PCB boards to hold LEDs, transistors, resistors, and 
microcontroller interface were designed using ExpressPCB Software and manufactured by 
ExpressPCB (ExpressPCB, www.expresspcb.com). All electronic components were 
purchased from Mouser Electronics (www.mouser.com) and assembled in house. LED 
arrays either displayed columns with different color LEDs (with identical LEDs within each 
column) to allow for evaluation of wavelength dependent activity or 96-LED arrays with 
identical LEDs (385 nm, Mouser#_593-VAOL5GUV8T4_385 nm; 390 nm, Mouser#_749-
UV5TZ-390-30_390 nm; 405 nm, Mouser#_749-UV5TZ-405-30_405 nm; 430 nm, 
Mouser#_638-MV8B01_430 nm; 470 nm, Mouser#_941-C503BBCNCV0Z0462_470 nm; 
502 nm, Mouser#_638-MV8G03_502 nm; 527 nm, Mouser#_941-
C503BGCNCY0C0792_527 nm; 562 nm, Mouser#_638-MV64521_562 nm; 591 nm, 
Mouser#_941-C503BACNCY252030_591 nm; 624 nm, Mouser#_941-
C503BRCNCW0Z0AA2_624 nm; 660 nm, Mouser#_696-LX5093SRC/F_660 nm). Per 
column current was set at 20 mA by Temperature Compensated Constant Current LED 
Driver ICs (Supertex Inc., Mouser# 689-CL25N3-G) and switched using NPN transistors 
(Mouser# 512-PN2222ABU).
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Microplate Stage—Microplate stages to hold LED arrays were designed using Adobe 
Illustrator and manufactured by laser cutting from black acrylic resin (Ponoko). The stages 
were designed with exchangeable faceplates to match top and bottom profiles of 96-well 
microplates, enabling illumination from top or bottom, respectively. For cell culture 
experiments, we included a matching 96-well mask that was manufactured by water jet 
cutting (ACP Waterjet) from 0.25” copper as heat sink to limit temperature changes within < 
0.5 °C. The LED arrays were connected to an Arduino microcontroller (Arduino Uno or 
Arduino Mega, www.arduino.cc) that was programmed to control individual LEDs, LED 
rows or LED columns within the array. The controller allowed modulation of LED intensity 
by modulating the on/off timing (PWM) or by directly modulating the voltage supplied. 
Exposure of each well can be individually programmed, enabling precise modulation of the 
light exposure with <10 ms resolution (limited by LED response). We have designed the 
integrated circuit of LEDs and microcontroller to be powered optionally by a power supply 
unit connected to a standard 110 V outlet, computer USB-port or by a battery-pack of 6 
conventional rechargeable C-cell batteries, which allows for use in a cell culture incubator 
for up to 16 h.
Biological Profiling
Biochemical HDAC assay—The light-dependent inhibitory activity of the test and 
reference compounds was determined as reported previously with minor modifications.20 
Full length recombinant HDAC proteins (BPS Biosciences) were diluted into HDAC assay 
buffer (50 mM HEPES, 100 mM KCl, 0.001% (v/v) Tween-20, 0.05% (w/v) bovine serum 
albumin (BSA), pH 7.4) and 100 μL/well dispensed (Multidrop, Thermofisher) into white 
96-well plates (Corning) followed by dispensing of test compounds from 10 mM stock 
solutions using an HP D300 Digital Dispenser (Hewlett-Packard). The LED-array was then 
placed on top of the 96-well plate and enzyme inhibitor solutions were exposed to light for 1 
h (470 nm, 17 mW/cm2). Light exposure was either continues at fixed intensity or 
modulated by on/off cycles at a frequency of 1 Hz. Following light exposure, HDAC 
substrate (final concentration HDAC1 (6 μM); HDAC2 (4.5 μM); HDAC3 (9.5 μM) and 10 x 
trypsin were added in 10 μL, and substrate turnover was measured in continuous kinetic 
mode (1 read/min) for 30 min on a TECAN Safire 2 multi-well plate reader (λex=345 nm, 20 
nm bandwidth, λem=440 nm, 20 nm bandwidth). Data were analyzed on a plate-by-plate 
basis for the linear range of fluorescence over time. The first derivative of data obtained 
from the plate capture corresponding to the mid-linear range was imported into analytical 
software (GraphPad Prism). Azobenzene-functionalized inhibitors show strong absorbance 
in the spectral range of the fluorescence signal, which results in an inhibitor concentration-
dependent decrease of fluorescence signal. The relative signal decrease is linearly correlated 
with the azobenzene concentration, but independent from the concentration of the substrate 
and the amount of the generated fluorescent product 7-AMC. We have therefore acquired 
standard curves to corrected raw intensity values (Supplemental Fig. 14). Replicate 
experimental data from incubations with inhibitor were normalized to controls. All reported 
biochemical experiments are representative examples of at least two independent biological 
replicates.
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Cell Culture—Human MCF-7 cells (ATCC) were propagated in RPMI media (+10%FBS 
+1% L-glutamine +1% Pen/Strep) at 37 °C and 5% CO2. Cell culture was routinely checked 
for mycoplasma contamination using the MycoAlert™ Mycoplasma Detection Kit (Lonza) 
according to the manufacturer’s protocol. Prior to assays, cells were transferred to phenol 
red free RPMI medium and seeded into black/clear bottom 96-well plates (BD Biosciences 
#BD356692) at 7,000 cells/well density for immunofluorescent assays and 10,000 cells/well 
for western blot analysis and L1000 gene expression experiments. One day post plating, 
COMET probes were added to cells using an HP D300 Digital Dispenser (Hewlett-Packard), 
and cells were exposed to light as indicated.
Western blot assay—Following the addition of vehicle control or COMET probes 
(BG14, BG47, BG48) at a final concentration of 25 μM, MCF-7 cells were exposed to 
varying amounts of 470 nm light (8.5 mW/cm2) for 16 h in a tissue culture incubator (37 °C, 
5% CO2). The light exposure was modulated at 1 Hz (no light, 250 ms on/750 ms off, 750 
ms on/250 ms off). Subsequently, cells were lysed and the relative amount of acetylated 
H3K9 was analyzed by standard western blot analysis (rabbit anti-H3K9ac antibody, 
Millipore #07-352 1:10,000, anti-rabbit-horseradish peroxidase (HRP) 1:2,000, Cell 
Signaling #7074) using anti β-Actin as loading control (Sigma A1978, anti-mouse-HRP Cell 
Signaling #7076 1:10,000). Fold increase over DMSO treated samples were quantified with 
ImageJ software (http://imagej.nih.gov/ij). Western blot assays were performed in triplicate 
with each treatment done in duplicate. Differences in mean acetylation levels comparing 
presence and absence of light were assessed using a two-sided t-test with p<0.05 considered 
significant.
Immunofluorescent Assay—Following the addition of vehicle control, CI-994, and 
BG14 at a final concentration of 25 μM, MCF-7 cells were exposed to no light or cycles of 
470 nm light (8.5 mW/cm2, 300 ms on/900 ms off) for 16 h in a tissue culture incubator 
(37 °C, 5 % CO2). Afterwards, cells were fixed with 4 % formaldehyde for 1 h, followed by 
a 20 min treatment with 100 % MeOH. Permeabilization and blocking was performed in 
PBS containing 0.1 % Triton X-100 and 2 % BSA. For immunofluorescent quantification of 
histone modification, cells were incubated overnight with anti-acetylated-H3K9 antibody 
(Millipore #07-352, 1:2,000), followed by a 1 h incubation with Alexa-594 conjugated 
secondary antibody (Molecular Probes A11012, 1:500). Images were captured by high-
content, automated, confocal microscopy using the IN Cell Analyzer 6000 (GE Healthcare), 
both with a 40x objective for high-resolution images and a 10x objective for quantification 
of acetylation signal intensity. Nuclear intensity of acetylated H3K9 was quantified in 4 
fields/well (> 3500 cells/well) and normalized to DMSO control wells. Immunofluorescent 
assays were performed in 3 independent biological replicates with treatments done in 
duplicate. A total of four fields per well were captured and >3500 cells per field were 
quantified. Error bars = s.d. . Comparisons of treatments were assessed using one-way 
analysis of variance (ANOVA) followed-up with a Tukey's Honest Significant Difference 
(HSD) post-hoc test with p<0.05 considered significant.
Time dependence and persistence of HDAC inhibition—Upon addition of BG14, 
CI-994 (both at 25 μM final concentration) or vehicle, MCF-7 cells were exposed to varying 
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amounts of light during a total assay time of 16 hours: 16h no light, 0.5h light & 15.5 h no 
light, 1 h light & 15 h no light, 2 h light & 14 h no light, 4 h light & 12 h no light, 8 h light 
& 8 h no light. Light cycles consisted of 470 nm light (8.5 mW/cm2) modulated at 1Hz (500 
ms on/off). After 16 hours, cells were fixed, stained, imaged, and quantified as described 
earlier (Immunofluorescent Assay). Nuclear intensity of acetylated H3K9 was quantified for 
9 fields/well with n≥3 per treatment. Acetylation values were normalized within each group 
to DMSO = 0 and CI-994 = 100%. Mean and s.d. values are shown. Two-sided t-test 
performed for each experimental condition.
Spatial control of HDAC inhibition—A) MCF-7 cells were plated in a 1-well chamber 
slide (Lab Tek Chamber slide #177372) at 750k cells in 5 mL media/chamber. One day post 
plating, cells were treated either with DMSO or BG14 at 25 μM and the chambers were 
placed over a single 5 mm LED (470 nm, 8.5 mW/cm2, pulsed at 300 ms on/600 ms off). 
Light exposure was conducted for 6 hours, followed by an additional 10 h treatment without 
light exposure before cells were fixed. Slides were stained as described earlier 
(Immunofluorescent Assay). The entire 1-well chamber slide was imaged with the IN Cell 
Analyzer 6000 (7 x 14 captures). The mean nuclear intensity for acetylated H3K9 was 
determined for each captured field and normalized to its site-specific DMSO field. The 
normalized mean H3K9ac values/field was used to create a heatmap. B) Wells of a 96-well 
culture plate were partially covered (50%) at the bottom with black tape prior to plating 
MCF-7 cells at 7.5k cells/well. Cells were treated for a total of 16 hours one day post plating 
with DMSO, CI-994, and BG14 (25 μM for both compounds) and exposed to light (470 nm, 
8.5 mW/cm2, 300 ms on/900 ms off cycles). Cells were fixed, stained, and imaged as 
previously described (Immunofluorescent Assay). To capture entire wells, 4 x 4 images were 
taken. For quantification, covered and light exposed halves in each well were treated 
independently. Nuclear intensity of acetylated H3K9 was determined and the fold change in 
comparison to appropriate (covered/light exposed well half) DMSO control was calculated. 
For visualization, shading correction was performed on all images. 4x4 images per well 
were used to create whole well montages in ImageJ. Subsequently, the Surface plot analysis 
plugin in ImageJ was used to create heatmaps for H3K9ac in each well. For each treatment, 
we used n=5. Mean and s.d. values shown. One way analysis of variance (ANOVA) 
followed-up with Tukey’s post-hoc test performed with p<0.05 considered significant.
L1000 Sample Production—MCF-7 cultures were treated with BG14, BG47, BG48 (1 
μM, 5 μM, and 25 μM), and CI-994 (1 μM and 25 μM), by transfer of compounds using an 
HP D300 Digital Dispenser (Hewlett-Packard). Subsequently, cells were exposed for 0%, 
25%, or 75% of time per 1 sec light cycle (470 nm, 8.5 mW/cm2) for a total of 16 h, and cell 
lysates were harvested according to the protocol provided by Genometry Inc. and stored at 
−80 °C. L1000 analysis was performed by Genometry Inc. All experiments were performed 
in quadruplicate.
Transcriptional Analysis—L1000 data consisting of landmark (LM) and inferred (INF) 
data that has been log2 transformed was obtained from Genometry, Inc. (full gene 
expression profiles are available upon request from data@genometry.com). All analysis of 
L1000 data used treatments that were represented relative to corresponding controls with the 
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robust z-scores. The robust z-scores for each feature calculated using the median and median 
absolute deviation (MAD) of the vehicle controls specific to the batch (4 to 6 vehicle 
controls in each of 6 batches total) of each sample. Because of the limited number of vehicle 
controls in each batch, MAD was thresholded to a minimum of 0.1 and the robust z-score 
was set to 0 if MAD was 0.
Gene Set Enrichment Analysis (GSEA) (http://www.broadinstitute.org/gsea/index.jsp) was 
used to assess whether signatures were enriched in treatments by the experimental 
compounds. GSEA was used in a pre-ranked list mode where enrichment is determined by 
the positions of features from the gene sets in the ranked lists of all the features. P-values for 
the significance of enrichment scores were found by permuting the gene sets (1000 
permutations). The ranked lists used by GSEA were created by calculating scores for each 
feature using either signal-to-noise ratio (SNR) for two class distinctions or cosine distance 
to a template for multi-class distinctions. SNR were calculated by finding the difference of 
the means of the two classes of samples divided by the sum of the standard deviations of the 
two classes of samples. SNR was used to create ranked lists of features that compared 
DMSO to a treatment for a specific compound, treatment time, light level, and dose (where 
the DMSO control had the same treatment time and light level). Cosine distance was used to 
rank features according to their similarity to a normalized ideal template where the template 
tries to select features that show increased effects with increasing dose and increasing light 
levels. Supplementary Fig. 15a shows the template prior to normalization (to zero mean and 
standard deviation of one) used for ranking features according to light and chemical 
concentration dose with each of the compounds. Each compound also had a no light dose 
response template as shown in Supplementary Fig. 15b to discover off-target effects for the 
compounds. Reference compounds used a three-value template (0,1,2 prior to normalization 
for DMSO, compound at low-dose, and compound at high dose) and were evaluated at zero 
light and maximum light. The gene sets that were used in GSEA came from the literature or 
were created by choosing the 100 highest and lowest scoring features associated with each 
ranked list (each treatment).
Identification of Light-Dependent Gene Signatures
SNR-based lists for BG14, CI-994 and C60 were reduced to landmark genes. A gene was 
scored as ‘active’ when its SNRs fulfilled either one of the following criteria:
a. abs(SNR) > 1.5;
b. abs(SNR[25 μM, 750 ms] - SNR[1 μM, 0 ms] ) > 1.5.
Genes were ranked by their score differences: SNR[25 μM, 750 ms] - SNR[1 μM, 0 ms] in 
descending order. CI-994 response gene list (in absence of light) is comprised of 432 genes. 
C60 response gene list (in absence of light) is comprised of 343 genes. BG14 response gene 
list contains a total of 256 genes.
The BG14 response gene list was subdivided into 3 categories:
A. a BG14 response gene was scored as off-target when it fulfilled the following 
criteria:
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a. abs(SNRNoLight)>1.5
b. abs(SNRLight –SNRNoLight) ≤1.5
22 BG14 off-target genes were identified.
B. a BG14 response gene was scored as mixed on-target when it fulfilled the following 
criteria:
a. abs(SNRNoLight) > 1.5
b. abs(SNRLight –SNRNoLight) > 1.5
47 BG14 mixed on-target genes were identified.
C. a BG14 response gene was scored as clean on-target when it fulfilled the following 
criteria:
a. abs(SNRNoLight) ≤1.5
b. abs(SNRLight –SNRNoLight) > 1.5
187 BG14 clean on-target genes were identified.
Lastly, we used Venn diagram analysis (www.cmbi.ru.nl/cdd/biovenn) to identify the Core 
Gene list (120) consisting of the overlap between the CI-994 response gene list and the 
BG14 clean on-target genes.
Density functional theory calculations
To find the lowest energy conformers, a solution phase conformational search using 
MacroModel (version 10.6, Schrödinger, LLC) was performed with OPLS_2005 35 as force 
field and Polak-Ribiere Conjugate Gradient (PRCG) as minimization method. The twenty 
(eight for CI-994 derivatives) lowest energy conformers were geometry optimized using 
density functional theory (DFT) calculations with B3LYP37 as functional and the 6-31+G(d) 
basis set. The vibrational frequencies were computed at the same level to verify that 
optimized structures are energy minima and to evaluate zero-point vibrational energies 
(ZPVE) and thermal corrections at 298 K. All calculations were performed using the 
Solvation Model Based on Density (SMD) solvent continuum as solvent method. 38 The 
electrostatic potentials (ESP) were calculated by performing a population analysis in solvent 
concerning CHelp scheme 36. All calculations were performed using Gaussian09 software. 
The ESP for the Zn-binding nitrogen and oxygen atoms for the lowest energy conformers, as 
well as the Boltzmann weights ESP values based on the twenty (eight for CI-994 
derivatives) lowest energy conformers, are provided in Supplementary Fig. 16.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Overview of photochromic HDAC inhibitor design for use in COMET
(a) Schematic of azobenzene trans/cis isomerization. (b) Theoretical model of the dose-
dependent activity of a photochromatic inhibitor as a function of the trans/cis isomer ratio. 
(c) Azobenzene-based COMET HDAC inhibitor design combining elements of DABCYL 
and the class I HDAC-selective HDAC inhibitors CI-994 and compound C60 to produce the 
hybrid structure of BG14 and BG48, respectively. (d) Structures of control compound BG12 
and HDAC1/2-biased COMET probe BG47. (e) Density functional theory (DFT) 
calculations (Gaussian 09) of the electrostatic potentials of CI-994, cis-BG14 and trans-
BG14 showed that the electrostatic potential of the zinc-chelating moieties (carbonyl oxygen 
and aniline nitrogen) in cis-BG14 are very similar to CI-994 and less negative than trans-
BG14.
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Figure 2. Optical properties and validation of light-dependent inhibitory activity toward 
recombinant HDACs of COMET probes
(a) Measurement of thermal relaxation half-life. Each data point represents the mean values 
of 128 independent measurements. A least-squared fit modeling a one-phase decay 
(Graphpad Prism) was used to determine the relaxation half-lives. T1/2 values are reported 
with 95% Confidence Intervals. (b) 8x12 LED array for high-throughput COMET probe 
profiling. (c) Light intensity and concentration-dependent inhibition of recombinant HDAC3 
deacetylase activity by BG14 (470 nm, Imax = 17 mW/cm2). Mean values of duplicate 
experiments. Dose dependent and light dependent (470 nm, 17 mW/cm2) activity of 
COMET probes and reference HDAC inhibitors against HDAC1(d), HDAC2(e) and 
HDAC3(f). Data represent mean values of duplicate experiments. Dose response estimation 
of HDAC target residence time of COMET probes. HDAC1 was incubated with BG47 (520 
nM) (g) or BG48 (520 nM) (h) and exposed to blue light (470 nm, 17 mW/cm2) for 1 h and 
then kept for varying time in the dark at room temperature to allow HDAC bound inhibitor 
to dissociate. After the indicated time (4, 8, 17 h), HDAC substrate was added, and 
enzymatic activity was measured in kinetic mode over 2 h.(i) Enzymatic activity relative to 
control following light exposure and dark phase recovery. RU – relative units, RFU – relative 
fluorescence units. (g–i) Data represent individual measurements of representative biological 
replicate.
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Figure 3. Light-dependent control of the human epigenome with COMET probes
(a) Immunofluorescence analysis of H3K9ac levels in MCF-7 cells treated with CI-994 (25 
μM) and BG14 (25 μM) in presence and absence of light (470 nm, 8.5 mW/cm2, 1Hz, 75% 
duty cycle). Scale bar = 20μm. (b) Quantification of H3K9ac intensity changes by 
automated confocal microscopy. Mean values +s.d. are shown (n=3). Significance values 
(n.s. – not significant, *** p < 0.001) were calculated by one-way ANOVA with Tukey’s 
post-hoc test (Graphpad PRISM). (c–e) Western blot analysis of H3K9ac levels in MCF-7 
cells after treatment with COMET probes at 25 μM and varying amounts of light exposure 
(Supplementary Fig. 8). Specifically, cells were exposed to no light or pulsing light (470 nm, 
8.5 mW/cm2) modulated at a frequency of 1 Hz (the duty cycle is expressed in % ON time). 
Values were normalized to vehicle treated cells and represent duplicate means of biological 
duplicates. (f) Persistence of HDAC inhibition. Quantification of relative 
immunofluorescence intensity of H3K9ac upon treatment of MCF-7 cells with DMSO, 
CI-994 (25 μM) and BG14 (25 μM) for a total of 16 h experimental time under varying 
duration of light exposure (470 nm, 8.5 mW/cm2, 1Hz, 50% duty cycle) at the beginning of 
the treatment period, followed by varying length of dark phases. Cellular H3K9 acetylation 
levels were normalized within each group to the positive control CI-994 = 100% and DMSO 
= 0. Mean values +s.d. are shown (n≥3). Detailed statistical values are provided in 
Supplementary Figure 8.
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Figure 4. Light-dependent spatial control of epigenetic regulation with the COMET probe BG14
Quantification of relative immunofluorescence intensity of H3K9ac upon treatment of 
MCF-7 cells with BG14 and light. (a) MCF-7 cells in a 1-well chamber slide were placed 
over a 5 mm LED (470 nm, 8.5 mW/cm2, 0.9 Hz, 33% duty cycle for 6 h, followed by 10 h 
without light exposure). The heatmap represents relative levels of histone H3K9ac (red 
indicates elevated H3K9ac levels). The white circle indicates position of LED. (b) Wells of a 
96-well culture plate were partially covered at the bottom of the plate prior to treatment of 
MCF-7 cells with DMSO control, BG14 and CI-994 in presence of light for 16 h followed 
by immunofluorescence staining for H3K9ac. Heatmaps of H3K9ac intensity throughout 
wells. Scale bar = 1mm. (c) Quantification of H3K9ac spatial intensity differences by 
automated, confocal microscopy. Mean values +s.d. (n=5). Significance values (n.s. – not 
significant, * p < 0.05, *** p < 0.001) were calculated by one-way ANOVA with Tukey’s 
post-hoc test (Graphpad PRISM).
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Figure 5. Characterization of COMET-mediated gene expression signatures in human cells
BG14 induces a light dose and compound concentration-dependent change in gene 
transcription in MCF-7 cells that is highly correlated with the gene expression signature of 
class I HDAC inhibitors. Specific examples of light-dependent up- and down-regulation of 
the HDAC inhibitor responsive landmark genes PAK1 (a) and CDK2 (b) in the presence of 
varying concentrations of BG14 and varying light exposure (no light, 250ms/750ms on/off, 
750ms/250ms on/off (470 nm, 8.5 mW/cm2, 1 Hz) for 1 6 h. Data points represent values of 
4 independent biological replicates. (c) Heat map of top 100 up- and down- regulated 
transcripts (landmark and inferred genes) that were specifically modulated by BG14 in light-
dependent fashion. No meaningful transcriptional changes were observed by BG14 
treatment alone or by light in the absence of inhibitor (control, 1 μM, 5 μM, 25μM; data 
represent average of n=4 measurements). (d) Gene Set Enrichment Analysis (GSEA) 
confirms the strongly correlated transcriptional response of CI-994 and BG14 (25 μM, 470 
nm, 8.5 mW/cm2, 1 Hz, 75% duty cycle, 1 6 h). p < 0.001 and FDR q < 0.001 (e) Venn 
diagram showing the overlap between CI-994 and C60 response genes and BG14 regulated 
light-dependent “on-target” and light-independent “off-target” genes, respectively.
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